Cadila Healthcare rose 1.29% to Rs 1,820 at 15:15 IST on BSE after the company said the Zydus group has received the market authorisation from the United States Food & Drug Administration to market Morphine Sulfate ER tablet. The company made announcement ... Business Standard, 2 months ago
Zydus Cadila bets big on oncology - Times of India, 1 month ago
Cadila Healthcare posts 47% rise in Q1 profit - Livemint.com, 3 weeks ago
1 images for "zydus group"
New Delhi: Pharmaceuticals major Zydus Group on Wednesday announced receipt of approval from the US Food and Drug Administration (FDA) to sell chronic pain reliever morphine sulfate tablets. "The product used in treatment of chronic pain or cancer ...NDTV Profit, 2 months ago Zydus gets USFDA nod to sell morphine sulfate tablets DNA India, 2 months ago Zydus gets USFDA nod for morphine sulfate tablets Money Control, 2 months ago
Group now has 100 approvals and has so far filed over 260 ANDAs BS Reporter | Ahmedabad June 24, 2015 Last Updated at 20:57 IST Ahmedabad-based pharma major Zydus Cadila has received the final approval from the US drug regulator to market Pyridostigmine ...Business Standard, 2 months ago Zydus Cadila gets approval for Pyridostigmine Bromide Tablets India Infoline, 2 months ago Cadila gets USFDA nod for Pyridostigmine Bromide tablets Business Standard, 2 months ago
Aug 31, 5:35 pm New Delhi, Aug.31 ( ANI ): Minister of State for the Prime Minister Office, Dr. Jitendra Singh, on Monday suggested that the government could provide public facilities and other support to the private sector for setting up ...Ani News, 3 days ago Jitendra Singh to inaugurate FICCI HEAL 2015′ Siasat Daily, 4 days ago
Johannesburg, August2015: Healthcare and technology leaderswill convene at the Protea Fire & Ice Hotel in Melrose Arch, Johannesburg on the 19 th of August 2015, for the African Innovator: Healthcare Innovation Summit , under the theme ...IT News Africa, 3 weeks ago
) - Pieris Pharmaceuticals, Inc . ( NASDAQ: PIRS ), a biotechnology company advancing its proprietary Anticalin ® biotherapeutic technologies, announced today that it will conduct a conference call on Thursday, August 13 at 10:00 AM (EDT) to ...Marketplace, 1 month ago Pieris Pharmaceuticals, Inc. (PIRS: null) | Pieris Pharmaceuticals Announces Closing of Over-Allotment Option in Public Offering of Common Stock OTC Markets, 1 month ago Pieris Pharmaceuticals Announces Closing of Over-Allotment Option in Public Offering of Common Stock Fat Pitch Financials, 1 month ago PIERIS PHARMACEUTICALS : to Host Second Quarter 2015 Investor Call on August 13th 4 Traders, 1 month ago
Teva Pharmaceutical Industries purchases Allergan's generics business for $40.5-billion. This may help generic-drug makers to acquire products that may be divested s part of the antitrust procedures in the US and fill their portfolio gaps. Teva ...MedIndia, 1 month ago Teva-Allergan deal a booster for Indian companies Economic Times, 1 month ago
Stock markets are expected to be range bound on Wednesday following Asian markets that were mostly higher on hopes that Beijing could stem the rout in its markets without damage to the economy. The BSE Sensex fell for the fourth straight session ...Financial Express, 1 month ago Epic Research Special Stock Market News 02 July 2015 Press Release Ping, 2 months ago
H Results today: Yes Bank, JSW Steel, Vedanta, Godrej Consumer Products, Dabur India, Mphasis, Nestle, Advanta, Allahabad Bank, Blue Dart Express, Castrol India, Essar Oil, Excel Crop Care, HEG, IFB Agro Industries, IIFL, Navin Fluorine, NHPC, ...Moneycontrol.com, 1 month ago Stocks in news: Infosys, HUL, Sun Pharma, PNB, Tinplate Moneycontrol.com, 1 month ago
CFO100 ROLL OF HONOR 2015 Cost Management Himanshu Agarwal Akzo Nobel India Limited Chief Financial Officer and Wholetime Director Sajal Gupta AMW Motors Limited Chief Financial Officer Anuj Aggarwal ...CFO India, 1 month ago
on your WebpageAdd Widget >Get your members hooked!